Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
93
datasets available to search
ShareScore release 0.9.0
Dataset results
93 results for “episodic migraine”
A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of Age
ClinicalTrials.gov study NCT04458857. IPD Sharing: YES. Countries: 9. Publications: 1.
Study of Sustained Benefit of AMG334 in Adult Episodic Migraine Patients
ClinicalTrials.gov study NCT03927144. IPD Sharing: NO. Countries: 18. Publications: 1.
Study of Efficacy and Safety of AMG 334 in Adult Episodic Migraine Patients
ClinicalTrials.gov study NCT03333109. IPD Sharing: YES. Countries: 11. Publications: 3.
Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine
ClinicalTrials.gov study NCT03939312. IPD Sharing: YES. Countries: 1. Publications: 4.
Head-to-head Study of Erenumab Against Topiramate in Patients With Episodic and Chronic Migraine
ClinicalTrials.gov study NCT03828539. IPD Sharing: YES. Countries: 1. Publications: 2.
Comparison of Therapeutic Effects of Greater Occipital Nerve Block, Topiramate, and Flunarizine on Episodic Migraine
ClinicalTrials.gov study NCT03712917. IPD Sharing: NO. Countries: 1. Publications: 2.
Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention
ClinicalTrials.gov study NCT02848326. IPD Sharing: Not stated. Countries: 1. Publications: 4.
A Randomized, Sham-controlled Study of gammaCore ® (nVNS) for Prevention of Episodic Migraine
ClinicalTrials.gov study NCT02378844. IPD Sharing: NO. Countries: 8. Publications: 1.
Rizatriptan for Episodic Dizziness in Vestibular Migraine
ClinicalTrials.gov study NCT02447991. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
ClinicalTrials.gov study NCT02559895. IPD Sharing: Not stated. Countries: 2. Publications: 9.
A Study Evaluating Oral Atogepant for the Prevention of Migraine in Japanese Participants With Chronic or Episodic Migraine
ClinicalTrials.gov study NCT04437433. IPD Sharing: YES. Countries: 1. Publications: 0.
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
ClinicalTrials.gov study NCT02025556. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
ClinicalTrials.gov study NCT02614196. IPD Sharing: YES. Countries: 12. Publications: 16.
Study of Oral Atogepant Tablets to Assess Change in Disease Activity in Adult Japanese Participants With Episodic Migraine
ClinicalTrials.gov study NCT05861427. IPD Sharing: YES. Countries: 1. Publications: 1.
Study of Two Digital Therapeutics for the Prevention of Episodic Migraine
ClinicalTrials.gov study NCT05853900. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine
ClinicalTrials.gov study NCT03700320. IPD Sharing: Not stated. Countries: 1. Publications: 6.
A Study of LY2951742 (Galcanezumab) in Japanese Participants With Episodic Migraine
ClinicalTrials.gov study NCT02959177. IPD Sharing: YES. Countries: 1. Publications: 6.
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
ClinicalTrials.gov study NCT02614183. IPD Sharing: YES. Countries: 3. Publications: 16.
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Episodic Migraine
ClinicalTrials.gov study NCT03303092. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine
ClinicalTrials.gov study NCT04252742. IPD Sharing: YES. Countries: 9. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.